Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

China flag China · Delayed Price · Currency is CNY
26.39
+0.33 (1.27%)
At close: Jan 23, 2026
51.84%
Market Cap3.17B
Revenue (ttm)319.72M
Net Income (ttm)16.46M
Shares Out119.99M
EPS (ttm)0.13
PE Ratio199.27
Forward PEn/a
Dividend0.10 (0.38%)
Ex-Dividend DateSep 25, 2025
Volume2,884,948
Average Volume3,290,650
Open26.06
Previous Close26.06
Day's Range25.97 - 26.49
52-Week Range14.13 - 42.25
Beta1.56
RSI54.60
Earnings DateApr 29, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile co... [Read more]

Sector Healthcare
Founded 1993
Employees 797
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300813
Full Company Profile

Financial Performance

In 2024, SHE:300813's revenue was 349.00 million, an increase of 29.33% compared to the previous year's 269.86 million. Earnings were 13.05 million, a decrease of -33.65%.

Financial Statements